Rising adoption of capsule formulations and a surge in demand for nutraceuticals and cosmeceuticals are pivotal factors driving market growth

Market Size – USD 1.86 billion in 2019, Market Growth - CAGR of 5.5%, Market Trends – Augmented investments in the pharmaceutical industry for R&D activities

The global empty capsules market is expected to be valued at USD 2.90 billion in 2027 from USD 1.86 billion in 2019, registering a CAGR of 5.5% through the forecast period. Empty capsules are stable shells that encapsulate or contain medicinal drugs and are administered in various dosage forms. The most widely used empty capsules are gelatin and non-gelatin capsules. Revenue from the global empty capsules market is estimated to register a significantly high growth rate in the upcoming years, owing to various favorable factors.

Get a Free PDF Sample Copy @ https://www.reportsanddata.com/sample-enquiry-form/3474

The significant parameters accountable for the growth of the global empty capsules market are the rising geriatric population, the surging prevalence of chronic and infectious diseases, the booming pharmaceutical industry, and the amplifying demand for nutraceuticals and cosmeceuticals, especially among consumers focused on health & wellness. Numerous benefits associated with the use of capsules, such as faster absorption, rapid disintegration, easy swallowing, and better palatability, have fueled the demand for capsules over other drug delivery forms like tablets, thereby inducing the growth of the global market. Empty capsules cover up the original taste of various cardiac therapy drugs, which helps the patient avoid a nauseated feeling. Therefore, the rising incidences of cardiovascular disorders and the growing demand for effective cardiac therapy drugs boost the market growth. Continuous developments in capsule delivery technologies further creates growth prospects for the market. However, ethical concerns regarding the consumption of capsules, such as bovine and porcine gelatin capsules, which contain animal-derived ingredients, restrain the market growth to a major extent.

Key findings of the report:
Based on product type, the gelatin sub-segment is expected to hold the most significant share of the global market over the estimated period. The low costs and high protein content of gelatin capsules and their rising availability for pharmaceutical manufacturing processes are the key factors predicted to bolster this segment’s growth.
Based on therapeutic application, the antibiotic and antibacterial drugs sub-segment is projected to emerge as the most dominant over the forecast timeline. The surging prevalence of numeorus infectious and chronic diseases across the globe and the higher susceptibility of the aged population to such diseases majorly propel this segment’s growth. However, the vitamins and dietary supplements segment is regarded as the fastest-growing market segment, mainly owing to the rising demand for multi-vitamin supplements and the increasing global initiatives to eradicate vitamin deficiency disorders and malnutrition.
The Asia Pacific region is touted as the leading regional market for empty capsules. The growing awareness about advanced nutraceuticals and cosmeceuticals, rising adoption of healthier lifestyles, the presence of advanced healthcare infrastructure, and the increasing disposable incomes of consumers are the pivotal factors boosting the market growth in this region.
The leading companies operating in the global empty capsules market are Mitsubishi Chemical Holdings Corporation Inc., ACG Associated Capsules Pvt. Ltd., Qualicaps Capsugel, Inc., JC Biological Technology Co. Ltd, Medicaps Ltd., CapsCanada Corporation, Patheon, Inc., Sunil Healthcare Ltd., and Roxlor LLC.

To get this Report at a Discount, click @ https://www.reportsanddata.com/discount-enquiry-form/3474

For the purpose of this study, the global empty capsules market has been segmented on the basis of product type, therapeutic application, end-use, and region:

By Product Type (Revenue: USD Billion; Volume: Million Tons; 2017-2027)
Gelatin Capsules
Non-gelatin capsules

By Therapeutic Application (Revenue: USD Billion; Volume: Million Tons; 2017-2027)
Antibiotic and antibacterial drugs
Antacids and antiflatulent preparations
Anti-inflammatory and anti-rheumatic drugs
Antianemic preparations
Vitamin and dietary supplements
Cough and cold preparations
Cardiac therapy drugs

By End-use (Revenue: USD Billion; Volume: Million Tons; 2017-2027)
Pharmaceutical industry
Nutraceutical industry
Cosmeceutical industry
Research laboratories

Browse the Full Report @ https://www.reportsanddata.com/report-detail/empty-capsules-market

By Region (Revenue: USD Billion; Volume: Million Tons; 2017-2027)
North America
U.S
Canada
Europe
U.K
Germany
France
BENELUX
Asia Pacific
China
Japan
South Korea
Rest of APAC
Latin America
Brazil
Rest of LATAM
MEA
Saudi Arabia
UAE
Rest of MEA

Thank you for reading this report. For further details relating to different aspects of the report or customization of the content, feel free to contact us. To get detailed information of the entire global market, or information for any specific requirements, reach out to us and we will customize the report as per your needs.